Studies a coronary sinus reducer for heart failure with preserved ejection fraction
Studies heart flow imaging after coronary sinus reducer placement in adults with heart failure.
Plain-language title generated from the registry record
Registry title: A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Key facts
- Where
- Rochester, United StatesSee the site
Where in United States
- Mayo ClinicRochester, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT07093528
- Record updated
- 27 February 2026
- Original description
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)Read full original descriptionShow less
CMR Substudy of Coronary Sinus Reducer for the Management of Symptomatic Heart Failure With a Preserved Ejection Fraction (HFpEF) Associated With Coronary Microvascular Dysfunction (CMD)
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Inclusion: Age ≥18; Enrollment in main CS-reducer HFPEF study IRB# 25-002292.
Exclusion: Metal implants that are not suitable for MRI; Inability or unwillingness of individual to give written informed consent.